3.4550
+0.0850
+(2.52%)
At close: April 17 at 4:00:00 PM EDT
3.5200
+0.07
+(1.88%)
After hours: April 17 at 5:14:35 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-29,382
-29,382
-27,927
-78,908
-108,235
Investing Cash Flow
-208
-208
-429
62,717
70,803
Financing Cash Flow
29,876
29,876
8,506
-7,942
42,554
End Cash Position
51,181
51,181
50,895
70,745
94,878
Interest Paid Supplemental Data
4,610
4,610
4,620
5,958
6,837
Capital Expenditure
-208
-208
-610
-313
-5,539
Issuance of Capital Stock
34,963
34,963
20,501
31,796
41,232
Issuance of Debt
--
--
--
--
77,782
Repayment of Debt
-5,045
-5,045
-10,000
-40,039
-78,045
Free Cash Flow
-29,590
-29,590
-28,537
-79,221
-113,774
12/31/2021 - 7/20/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MGNX MacroGenics, Inc.
1.2600
+6.78%
CTMX CytomX Therapeutics, Inc.
0.6560
+4.18%
ASMB Assembly Biosciences, Inc.
10.03
+0.25%
MRSN Mersana Therapeutics, Inc.
0.3547
+5.63%
KZR Kezar Life Sciences, Inc.
4.1600
+2.46%
CLSD Clearside Biomedical, Inc.
0.8600
-1.13%
GLYC GlycoMimetics, Inc.
0.2230
+0.45%
ANTX AN2 Therapeutics, Inc.
1.2600
-1.56%
DRMA Dermata Therapeutics, Inc.
0.7290
+1.25%
YMAB Y-mAbs Therapeutics, Inc.
4.6900
+3.30%